President Trump Will Nominate Pro-Life Doctor Heidi Overton as FDA Director
President Donald Trump is expected to nominate Dr. Heidi Overton, a physician and White House health policy adviser, as the next commissioner of the Food and Drug Administration.
Overton currently serves as deputy director for the White House Domestic Policy Council, advising the president on health policy. She previously served as chief policy officer for the America First Policy Institute, where she led its Center for a Healthy America, and was a fellow in the first Trump White House from 2019 to 2020.
Board-certified in public health and general preventive medicine, she trained as a general surgery resident at Johns Hopkins Hospital and earned a doctorate in clinical investigation from the Johns Hopkins Bloomberg School of Public Health.
SUPPORT LIFENEWS! If you want to help fight abortion, please donate to LifeNews.com!
In an article appearing at LifeNews, Overton confirmed that the science is clear and unborn babies are human beings.
The Left goes on and on about “Follow the Science” except when it comes to the abortion debate. Medical treatments and technology have drastically changed and improved since 1973.
Women can now see a baby inside their womb, watch it move and breathe, take home a picture and share it with friends on social media. The power of technology and improvements in medical care have changed the abortion debate towards pro-life arguments which is why the Left doesn’t use the “Follow the science” mantra with abortion.
New ultrasound technology now allows doctors and parents to see a baby’s development in incredible detail — one medical review article states this encourages maternal-fetal bonding. Improved treatments for extremely pre-term infants have improved survival with a 2022 academic study finding that 78% of infants born at 22-28 gestational weeks survive to go home with their parents.
Doctors can now perform intrauterine surgeries to treat conditions before the baby could live outside the womb, also known as “viability” — if the baby is wanted. That distinction is critical. Doctors change their language based on that one factor.
Take a standard 20-week ultrasound, for example. If a pregnancy is wanted, the doctor will tell the parents at their first ultrasound that the baby is healthy and developing normally. If a pregnancy is unwanted, the doctor in most U.S. states will tell the parents that the fetus is not yet viable so abortion is an option. Subjectively describing medical imaging findings based on whether the baby is wanted or unwanted is the opposite of science.
The pro-life Americans United for Life informed LifeNews that it has endorsed the selection.
John Mize, CEO of Americans United for Life, stated, “Dr. Overton is the right candidate. She has the scientific and medical background that will enable her to perform an objective analysis of the dangers chemical abortion poses to women. Americans United for Life supports Dr. Overton as the next Commissioner of the FDA.”
Sarah Zagorski, senior director of public relations and communications at Americans United for Life, added, “We believe Dr. Overton has an opportunity to help strengthen restrictions on the chemical abortion regimen, which, in this post-Dobbs era, has raised serious concerns about the safety and well-being of women and girls. Beyond the potential physical risks, the ease with which these drugs can be obtained online may also create opportunities for abuse and violence, particularly when they can be purchased by individuals seeking to place women in dangerous or coercive situations.”
The move maintains the longstanding tradition of appointing a medical doctor to lead the FDA. Overton would need Senate confirmation to assume the role.
Pro-life leaders see her medical expertise and policy background as vital for protecting women and unborn children by scrutinizing the risks of chemical abortion drugs.
